Stage Iiib Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Stage Iiib Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating MRI-guided adaptive radiation therapy with concurrent chemotherapy and consolidation durvalumab in inoperable Stage…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery [Phase 2]
This Phase 2 clinical trial update reports results for a hypofractionated boost before chemoradiation in patients with stage II–III non-smal…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Evaluating Modifiable Biomarkers for the Prediction of Immunotherapy Response and Toxicity
A completed clinical trial evaluating modifiable biomarkers to predict immunotherapy response and toxicity in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial of FR901228 in patients with refractory or progressive small cell lung cancer or non-small cell lung cancer has compl…
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma [Phase 1]
Phase 1 trial assessing trigriluzole in combination with nivolumab and pembrolizumab for various metastatic or unresectable solid tumors and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial assessing whether adding metformin hydrochloride to chemotherapy and radiation improves outcomes for Stage III non-small cel…
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: 18F-FSPG PET/CT for Cancer Patients on Therapy [Phase 2]
Phase 2 clinical trial update on 18F-FSPG PET/CT for cancer patients undergoing therapy; study status completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery [NA]
The Wake Forest University Health Sciences trial NCT02566421, evaluating genomic sequencing to guide treatment for metastatic, recurrent, or…
-
CLINICAL_TRIALS trial_result · 2017-02-02Clinical Trial Update: Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy [Phase 3]
Phase 3 trial investigating sunitinib malate as maintenance therapy after chemotherapy in stage IIIB/IV non-small cell lung cancer; study co…
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial results evaluating the combination of chemotherapy, radiation therapy, and bevacizumab in newly diagnosed, unresectable stage …
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: RO4929097 in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Recently Completed Treatment With Front-Line Chemotherapy [Phase 2]
Phase 2 trial of RO4929097 in advanced non-small cell lung cancer patients recently treated with front-line chemotherapy; the study was term…
-
CLINICAL_TRIALS trial_result · 2015-09-14Clinical Trial Update: S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
This Phase 2 clinical trial (S0536) evaluated the combination of cetuximab, paclitaxel, carboplatin, and bevacizumab in patients with advanc…
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: E7389 in Treating Patients With Recurrent or Progressive Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial of eribulin mesylate (E7389) in recurrent or stage IIIB/IV non-small cell lung cancer has completed, and results were posted.
-
CLINICAL_TRIALS trial_result · 2014-10-10Clinical Trial Update: Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating the combination of celecoxib and erlotinib in former smokers with stage IIIB or stage IV non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer [Phase 2]
Phase II trial assessing carboplatin plus gemcitabine in patients with Stage IIIB non-small cell lung cancer and Stage IV non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated a combination of docetaxel, cisplatin, pegfilgrastim, and erlotinib in patients with stage IIIB or stage IV non-sm…
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer [Phase 2]
This is a completed Phase 2 trial update evaluating Erlotinib in combination with Celecoxib for patients with Stage IIIB or Stage IV recurre…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated first-line therapy with docetaxel plus cetuximab or docetaxel plus bortezomib in patients with Stage IIIB or Stage…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating the combination of suramin, paclitaxel, and carboplatin in patients with stage IIIB or stage IV non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer [Phase 2, Phase 3]
A phase 2/3 trial evaluated adding bevacizumab to standard chemotherapy for advanced, metastatic, or recurrent non-small cell lung cancer; t…
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery [Phase 3]
A Phase 3 trial evaluating whether adding Gefitinib to combination chemotherapy and radiation therapy improves outcomes for unresectable sta…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating erlotinib with radiation therapy and chemotherapy for inoperable Stage III non-small cell lung cancer was terminate…
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab [Phase 2]
This Phase 2 trial evaluated a regimen of radiation therapy with bevacizumab, paclitaxel, and carboplatin in patients with unresectable Stag…